aTyr Pharma | LIFE - Net Income


aTyr Pharma reported $24.56M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Ardelyx USD -407K 562K Dec/2025
aTyr Pharma USD 24.56M 50.3M Dec/2025
Biogen USD 319.5M 368.4M Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Cipla INR 5.55B 1.21B Mar/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Curis USD 19.36M 31.16M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
Grifols EUR 114.37M 34.03M Dec/2025
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
United Therapeutics USD 274.9M 89.4M Mar/2026
Xoma USD -17.24M 33.23M Sep/2024